ArticleClinical & translational immunology2024

Lymphocyte activation gene 3 served as a potential prognostic and immunological biomarker across various cancer types: a clinical and pan-cancer analysis.

Yifan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.